157 related articles for article (PubMed ID: 28539697)
1. Physical Activity Levels in Individuals with Cystic Fibrosis-Related Diabetes.
Currie S; Greenwood K; Weber L; Khakee H; Legasto M; Tullis E; Wu K; Tsang A; Szego E; Mathur S
Physiother Can; 2017; 69(2):171-177. PubMed ID: 28539697
[No Abstract] [Full Text] [Related]
2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial.
Radtke T; Kriemler S; Stein L; Karila C; Urquhart DS; Orenstein DM; Lands LC; Schindler C; Eber E; Haile SR; Hebestreit H;
J Cyst Fibros; 2023 Jan; 22(1):31-38. PubMed ID: 35803884
[TBL] [Abstract][Full Text] [Related]
4. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
5. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
6. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
7. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
[TBL] [Abstract][Full Text] [Related]
8. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
9. Advances in cystic fibrosis-related diabetes: Current status and future directions.
Lurquin F; Buysschaert M; Preumont V
Diabetes Metab Syndr; 2023 Nov; 17(11):102899. PubMed ID: 37939435
[TBL] [Abstract][Full Text] [Related]
10. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
Yung B; Kemp M; Hooper J; Hodson ME
Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
[TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
Gilmour JA; Sykes J; Etchells E; Tullis E
Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
[TBL] [Abstract][Full Text] [Related]
13. Abnormal glucose tolerance in a pediatric cystic fibrosis cohort: Trends in clinical outcomes and associated factors in the preceding years.
Nguyen CQT; Denis MH; Chagnon M; Rabasa-Lhoret R; Mailhot G
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):277-285. PubMed ID: 32981797
[TBL] [Abstract][Full Text] [Related]
14. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
15. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
[TBL] [Abstract][Full Text] [Related]
16. A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis.
Potter KJ; Racine F; Bonhoure A; Boudreau V; Bélanger N; Coriati A; Shohoudi A; Lavoie A; Senior PA; Mailhot G; Rabasa-Lhoret R
Diabetes Metab; 2023 Jul; 49(4):101455. PubMed ID: 37271306
[TBL] [Abstract][Full Text] [Related]
17. Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.
Mohan K; Miller H; Burhan H; Ledson MJ; Walshaw MJ
Pediatr Pulmonol; 2008 Jul; 43(7):642-7. PubMed ID: 18500737
[TBL] [Abstract][Full Text] [Related]
18. [Screening and management of glucose metabolism disorders in cystic fibrosis patients. Practices survey in 4 French reference centers].
Haesebaert J; Bourdy S; Perceval M; Chabloz C; Nove-Josserand R; Reix P; Llerena C; Wion N; Touzet S
Arch Pediatr; 2009 Nov; 16(11):1435-42. PubMed ID: 19811898
[TBL] [Abstract][Full Text] [Related]
19. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
[TBL] [Abstract][Full Text] [Related]
20. Physical Activity and Sedentary Behavior in Adults With Cystic Fibrosis: Association With Aerobic Capacity, Lung Function, Sleep, Well-Being, and Quality of Life.
Curran M; Tierney AC; Button B; Collins L; Kennedy L; McDonnell C; Sheikhi A; Jurascheck A; Casserly B; Cahalan R
Respir Care; 2022 Mar; 67(3):339-346. PubMed ID: 34815328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
